克利哮喘針
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
EPINEPHRINE HCL;;POST PITUITARY EXTRACT
Available from:
資生股份有限公司 台南巿忠義路２段１３４號 (68781707)
Pharmaceutical form:
注射劑
Composition:
EPINEPHRINE HCL (1212000610) (0.1%),0.800GM; POST PITUITARY EXTRACT (6828000401) 0.010GM
Units in package:
安瓿
Class:
製 劑
Prescription type:
限由醫師使用
Manufactured by:
DR. KADE PHARMAZEUTISCHE FABRIK GMBH OPELSTRABE 2, 7750 CONSTANCE DE
Therapeutic indications:
支氣管性氣喘
Product summary:
註銷日期: 1986/10/06; 註銷理由: 中文品名變更;;內政部許可證展延; 有效日期: 1985/07/17; 英文品名: ASTHMOLYSIN
Authorization status:
已註銷
Authorization date:
1970-07-17
